The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADMA BIOLOGICS INC COM 000899104 33,412 3,608,171 SH   SOLE   3,608,171 0 0
AGILE THERAPEUTICS INC COM 00847L100 25,631 2,983,797 SH   SOLE   2,983,797 0 0
CATALENT INC COM 148806102 20,991 715,673 SH   SOLE   715,673 0 0
CEMPRA INC COM 15130J109 75,354 2,193,060 SH   SOLE   2,193,060 0 0
CHIMERIX INC. COM 16934W106 47,260 1,022,943 SH   SOLE   1,022,943 0 0
DERMIRA INC COM 24983L104 19,341 1,102,046 SH   SOLE   1,102,046 0 0
ESPERION THERAPEUTICS INC. COM 29664W105 133,851 1,637,125 SH   SOLE   1,637,125 0 0
INTERSECT ENT INC COM 46071F103 10,021 350,000 SH   SOLE   350,000 0 0
LOMBARD MED INC COM G55598109 3,900 886,363 SH   SOLE   886,363 0 0
LOXO ONCOLOGY INC COM 548862101 62,248 3,452,493 SH   SOLE   3,452,493 0 0
PARATEK PHARMACEUTICALS INC COM 699374302 17,593 682,680 SH   SOLE   682,680 0 0
PERNIX THERAPEUTICS HLDGS IN COM 71426V108 11,899 2,010,000 SH   SOLE   2,010,000 0 0
ROKA BIOSCIENCE INC COM 775431109 2,677 1,029,693 SH   SOLE   1,029,693 0 0
SORRENTO THERAPEUTICS INC COM NEW 83587F202 30,022 1,703,855 SH   SOLE   1,703,855 0 0
T2 BIOSYSTEMS INC COM 89853L104 40,953 2,523,300 SH   SOLE   2,523,300 0 0
TRANSENTERIX INC. COM NEW 89366M201 25,007 8,335,819 SH   SOLE   8,335,819 0 0
VERSARTIS INC COM 92529L102 34,695 2,279,568 SH   SOLE   2,279,568 0 0
ZELTIQ AESTHETICS INC COM 98933Q108 76,702 2,602,738 SH   SOLE   2,602,738 0 0